Bristol Myers Squibb

2022 Breast Cancer Guide to Patient Support Services

Bristol Myers Squibb Access Support


Through its Access Support program, Bristol Myers Squibb (BMS) offers a variety of options to help provide eligible patients access to its oncology medications and reimbursement support services. The program offers benefits reviews, prior authorization assistance, and appeal process support, as well as an easy-to-initiate copay assistance process and information on financial support. The support offered varies based on the patient’s prescribed medication and insurance status. See the Table for program information for patients taking Abraxane.

BMS Access Support

BMS Oncology Co-Pay Assistance Program

Access to certain BMS oncology products is supported through the BMS Oncology Co-Pay Assistance Program. This program is designed for commercially insured patients who need financial assistance with out-of-pocket deductibles, copays, or coinsurance.

Enrolled patients pay the first $25 of the copay for each dose of a BMS medication covered by this program. BMS will cover the remaining amount up to a maximum of $25,000 per year, per patient, per product. Restrictions apply. Final determination of program eligibility is based upon review of a completed application.

Visit BMS Access Support for access to program information pertaining to the drug you have prescribed for your patient. More information can also be obtained by calling BMS Access Support at 800-861-0048.

Patients with government insurance, such as Medicare, Medicaid, or TRICARE, are not eligible for copay assistance programs sponsored by BMS. See information below regarding options for these patients, including the BMS Patient Assistance Foundation.

Enrollment forms for the BMS Oncology Co-Pay Assistance Program are available online. Print the enrollment form, which must be completed and signed by the patient and the provider and faxed to BMS. For patients prescribed Abraxane, fax to 800-822-2496. The BMS Access Support program will determine the patient’s eligibility, including verification of insurance coverage and benefits amount.

BMS Patient Assistance Foundation

For patients who have government insurance, are underinsured, or have no prescription drug insurance, BMS Access Support can make a referral to independent charitable foundations. Each foundation has its own eligibility criteria and evaluation process. BMS cannot guarantee that a patient will receive assistance.

The BMS Patient Assistance Foundation (BMSPAF) may provide medicine, free of charge, to eligible, uninsured patients who have an established financial hardship. BMSPAF may be able to provide assistance to patients who:

  • Live in the United States, Puerto Rico, or the US Virgin Islands
  • Are being treated by a US licensed prescriber
  • Are being treated with the medicine as an outpatient
  • Do not have insurance coverage for a listed medicine
  • Were prescribed a BMS medicine for cancer (even if their annual household income is higher than $38,640 for a single person or $52,260 for a family of 2).

These are just some of the eligibility requirements, and other eligibility criteria may apply. For more information, call BMS at 800-736-0003 or visit

The application for the BMSPAF can be downloaded from Both the patient and the healthcare provider must complete appropriate sections, sign, and date the application. Proof of income must be submitted with the application. Fax documents to BMSPAF at 888-776-2370. Enrollment is valid for 1 year; re-enrollment every year is required to continue in the program.

TABLE BMS Breast Cancer Treatment

Patient support program

Abraxane (paclitaxel protein-bound particles) for injectable suspension
Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy
Patient support program

© Amplity Health. All Rights Reserved. Privacy Policy.